Tiziano Barbui
- Hematology top 0.01%
- Acute Myeloid Leukemia Research 145
- Chronic Myeloid Leukemia Treatments 69
- Platelet Disorders and Treatments 64
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 260
- Hemoglobinopathies and Related Disorders 48
- Rheumatology top 0.01%
- Eosinophilic Disorders and Syndromes 102
- Internal Medicine top 0.1%
- Nephrology top 0.2%
-
- Kruppel-like factors research 109
-
- Acute Lymphoblastic Leukemia research 45
- Co-authors
- Guido FinazziAlessandro M. VannucchiAlessandro RambaldiAyalew TefferiAnna FalangaHeinz GisslingerGiovanni BarosiSergio Cortelazzo
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Tiziano Barbui
540 papers receiving 29.4k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hematology 17.8k
- Genetics 16.6k
- Rheumatology 10.9k
- Internal Medicine 1.8k
- Nephrology 1.4k
Countries citing papers authored by Tiziano Barbui
This map shows the geographic impact of Tiziano Barbui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiziano Barbui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiziano Barbui more than expected).
Fields of papers citing papers by Tiziano Barbui
This network shows the impact of papers produced by Tiziano Barbui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiziano Barbui. The network helps show where Tiziano Barbui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tiziano Barbui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 62 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 51 | |
| 8 | 2021 | 40 | |
| 9 | 2021 | 63 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 40 | |
| 12 | 2020 | 15 | |
| 13 | 2018 | 1 | |
| 14 | The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussionbreakdown → | 2018 | 383 |
| 15 | 2017 | 15 | |
| 16 | 2013 | 24 | |
| 17 | 2009 | 196 | |
| 18 | 2008 | 79 | |
| 19 | 2007 | 77 | |
| 20 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelbreakdown → | 2007 | 604 |
About Tiziano Barbui
Tiziano Barbui is a scholar working on Genetics, Hematology and Rheumatology, having authored 551 papers that have together received 30.4k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (260 papers), Acute Myeloid Leukemia Research (145 papers), Kruppel-like factors research (109 papers), Eosinophilic Disorders and Syndromes (102 papers), Chronic Myeloid Leukemia Treatments (69 papers), Platelet Disorders and Treatments (64 papers), Hemoglobinopathies and Related Disorders (48 papers) and Acute Lymphoblastic Leukemia research (45 papers). The work is most often cited by research in Hematology (17.8k citations), Genetics (16.6k citations) and Rheumatology (10.9k citations). Tiziano Barbui has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Guido Finazzi, Alessandro M. Vannucchi, Alessandro Rambaldi, Ayalew Tefferi, Anna Falanga, Heinz Gisslinger, Giovanni Barosi, Sergio Cortelazzo, Francesco Rodeghiero and Alessandra Carobbio. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.